International Clinical Trial: Radiomics-based habitat analysis and deep learning prediction of EGFR and KRAS gene mutation status in non-small cell lung cancer and their response to targeted therapy

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134159) titled 'Radiomics-based habitat analysis and deep learning prediction of EGFR and KRAS gene mutation status in non-small cell lung cancer and their response to targeted therapy' on Oct. 11.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: First Hospital Of Nanping

Condition: Cough, sputum production, hemoptysis

Intervention: Training set,:N/A Validation set:N/A

Recruitment Status: Not Recruiting

Phase: Retrospective study

Date of First Enrollment: 2025-09-01

Target Sample Size: Training set,:108;Validation set:252;Hospital 2:90;

Countries of Recruitment: China

To know more, vis...